40 studies found for:    " September 21, 2011":" October 21, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection
Conditions: HIV;   Pregnancy
Interventions: Behavioral: PartnerPlus Intervention;   Other: Usual Care
22 Recruiting Renal Transplantation and Raltegravir in HIV-Infected Patients
Conditions: HIV-1 Infection;   Chronic Renal Insufficiency
Intervention: Drug: Raltegravir
23 Completed An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection
Condition: Neoplasms
Intervention:
24 Completed Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors
Conditions: HIV;   Dyslipidemia
Interventions: Drug: Truvada® (300 mg tenofovir disoproxil fumarato/200 mg emtricitabine);   Drug: Placebo
25 Completed Obesity in HIV After Antiretroviral Therapy
Conditions: HIV;   AIDS;   Obesity
Intervention: Drug: antiretroviral therapy
26 Active, not recruiting Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM
Condition: HIV
Intervention: Behavioral: Peer Navigator Intervention
27 Enrolling by invitation Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments
Conditions: HIV;   Brain Tumors;   Neurofibromatosis 1
Intervention:
28 Completed Comparative Tolerability of Protease Inhibitors
Condition: HIV
Intervention:
29 Recruiting Korean Post-marketing Surveillance for Reyataz®
Condition: HIV-1
Intervention: Drug: No Intervention
30 Terminated Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
Conditions: Hepatitis;   HIV/AIDS
Interventions: Drug: Boceprevir;   Drug: Peg-Interferon-alfa 2B;   Drug: Ribavirin
31 Completed
Has Results
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
Condition: HIV-1 Infection
Intervention: Drug: Rifaximin
32 Active, not recruiting Immunogenicity and Safety of HPV Vaccine in HIV-infected Pre-adolescent Girls and Boys in Kenya
Conditions: Human Papillomavirus;   HIV-1 Infection
Intervention: Biological: Gardasil vaccine
33 Completed Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth
Conditions: HIV-1 Infection;   H1N1;   Influenza;   Flu
Interventions: Biological: FluMist;   Biological: Fluvirin;   Biological: Fluzone
34 Recruiting Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Conditions: Castleman Disease;   Castleman's Disease;   Giant Lymph Node Hyperplasia
Interventions: Drug: Zidovudine;   Drug: Tocilizumab;   Drug: Valganciclovir
35 Completed A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan
Condition: Contraception
Intervention:
36 Completed GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects
Condition: Healthy
Intervention: Drug: dolutegravir
37 Active, not recruiting Safety,Effectiveness and Acceptability of Sino-implant II in DR
Condition: Contraception
Interventions: Drug: Jadelle;   Drug: Sino-implant (II)
38 Recruiting Bridges to the Future: Economic Empowerment for AIDS-Orphaned Children in Uganda
Conditions: Poverty;   Orphaned Children;   AIDS Orphans
Interventions: Behavioral: Bridges;   Behavioral: Bridges PLUS;   Other: Usual Care
39 Recruiting Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)
Condition: Amphetamine-Related Disorders
Interventions: Drug: Naltrexone;   Drug: Placebo
40 Completed A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Nelfinavir;   Drug: Nelfinavir Mesylate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years